TI
AGIO icon

Turner Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Turner Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-27,880
Closed -$668K – 639
2013
Q4 		$668K Sell
27,880
-46,330
-62% -$1.06M 0.01% 488
2013
Q3 		$2.07M Buy
+74,210
New +$2.05M 0.03% 413

Other funds holding AGIO

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Turner Investments's AGIO Position: Q1 2014 in Review

Turner Investments sold out of Agios Pharmaceuticals (AGIO) in Q1 2014, closing a stake of 27,880 shares — an estimated $668K sold.

Turner Investments first reported a position in AGIO in Q3 2013 and held it in 2 quarters. The position peaked at $2.07M in Q3 2013. 74 funds tracked by Wall St. Rank hold AGIO as of Q1 2014.

  • Turner Investments reported no remaining Agios Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Turner Investments sold 27,880 Agios Pharmaceuticals shares in Q1 2014, an estimated $668K.
  • Turner Investments first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • Turner Investments's Agios Pharmaceuticals position peaked at $2.07M in Q3 2013.
  • 74 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2014.

Based on Turner Investments's 13F filing for Q1 2014, filed 12 May 2014.